Page last updated: 2024-12-10

1-o-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

## 1-O-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine (C16:0/20:4 PC)

This is a complex lipid molecule, often referred to as **PAF**, which stands for **platelet-activating factor**. It plays a crucial role in various physiological processes, making it an important subject of research.

**Let's break down its structure:**

* **1-O-hexadecyl:** This part refers to a 16-carbon saturated fatty acid (palmitic acid) attached to the first carbon of glycerol.
* **2-arachidonyl:** This part refers to a 20-carbon polyunsaturated fatty acid (arachidonic acid) attached to the second carbon of glycerol.
* **sn-glycero-3-phosphocholine:** This indicates the glycerol backbone with a phosphate group attached to the third carbon, and a choline head group attached to the phosphate.

**Why is PAF important for research?**

PAF is a potent bioactive lipid with diverse effects on various cell types. Its importance in research stems from its involvement in:

* **Inflammation:** PAF is a potent pro-inflammatory mediator, contributing to inflammation by attracting immune cells like neutrophils and platelets to the site of injury.
* **Hypersensitivity reactions:** PAF plays a key role in anaphylaxis, a severe allergic reaction characterized by bronchospasm, vasodilation, and hypotension.
* **Platelet activation:** As the name suggests, PAF is a potent activator of platelets, leading to their aggregation and release of pro-inflammatory mediators.
* **Cardiovascular function:** PAF can induce vasoconstriction and increase vascular permeability, impacting blood pressure and blood flow.
* **Neurological function:** PAF has been implicated in neurological disorders like Alzheimer's disease and stroke.

**Research Significance:**

The potent biological effects of PAF make it a significant target for research in various areas:

* **Drug development:** Understanding PAF's mechanisms of action could lead to development of new drugs to treat inflammatory diseases, allergies, and cardiovascular disorders.
* **Disease pathogenesis:** Research on PAF is crucial for understanding the role of inflammation and platelet activation in various diseases.
* **Cell signaling:** PAF is a key player in cell signaling pathways, making it an important subject of study for understanding cell communication and function.

**Overall:** 1-O-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine (PAF) is a complex lipid molecule with diverse and potent biological effects. Its importance for research lies in its potential to unlock new insights into inflammation, allergic reactions, cardiovascular health, and neurological diseases, ultimately leading to advancements in drug development and disease management.

1-O-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine: RN given refers to (all-Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438369
MeSH IDM0126869

Synonyms (7)

Synonym
2-((5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoyloxy)-3-(palmitoyloxy)propyl 2-(trimethylammonio)ethyl phosphate
[3-hexadecanoyloxy-2-[(5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
3,5,8-trioxa-4-phosphaoctacosa-13,16,19,22-tetraen-1-aminium, 4-hydroxy-n,n,n-trimethyl-9-oxo-7-(((1-oxohexadecyl)oxy)methyl)-, inner salt, 4-oxide, (all-z)-
6931-56-2
1-o-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine
1-palmitoyl-2-arachidonyl-gpc
2-arachidonoyl-1-palmitoyl-sn-glycero-3-phosphocholine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (23.53)18.7374
1990's15 (44.12)18.2507
2000's10 (29.41)29.6817
2010's1 (2.94)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]